Wisp collaborates with Mount Sinai to expand access to PrEP and HIV prevention across New York State. New Collaboration Connects Telehealth-First PrEP Access with Leading Health System Infrastructure NEW YORK-(BUSINESS WIRE)-Wisp, the largest pure play women's telehealth company in the U.S., today announced a collaboration with the Mount Sinai Health System, one of the largest academic medical systems in the New York metro area, to expand access to PrEP and HIV prevention to sexually active men, women and individuals across New York State. This collaboration is the first fully remote HIV prevention program launched by a New York City medical system - enhancing privacy, convenience, and access to testing that reduces risk of HIV transmission. Barriers such as stigma, limited access to providers, insurance complexity, and distrust of the healthcare system continue to prevent patients from accessing care. Only 36 percent of people who could benefit from PrEP have been prescribed it - despite decades of progress, access remains limited. In 2024, New York City had 1,791 new diagnoses of HIV and the majority came from Black, Latino, and Gay communities. "It's unacceptable that so many people still can't access PrEP, given it is one of the most effective solutions we have today to prevent HIV," said Monica Cepak, CEO of Wisp. "Our digital-first model, combined with Mount Sinai's clinical leadership is creating a more accessible, patient-centered approach to prevention - and not only helping people start PrEP, but stay on it." Wisp's PrEP program is designed to remove the biggest barriers to starting and staying on treatment. The program is covered by most commercial/private insurance, with 99% of patients paying $0, and includes at-home testing options, discreet delivery, and prescriptions available within 24-48 hours of lab results. By making required quarterly testing easier to complete, the model supports long-term adherence, not just initial uptake. "At Mount Sinai, our commitment goes beyond just HIV prevention - we're rethinking how care is delivered across the board to make it more proactive, accessible, and patient-centered," said Nicholas Gavin, MD, MBA, MS, Vice President, Chief Clinical Innovation Officer, and Associate Chief Medical Information Officer for Digital Health of the Mount Sinai Health System. "This collaboration is an extension of that, helping us meet people where they are, remove barriers, and bring evidence-based prevention like PrEP into every day, easy to access care across New York." Mount Sinai's Institute for Advanced Medicine first launched a hybrid tele-PrEP program in 2022 that still required patients to make on-site clinical visits to complete lab work. Mount Sinai now offers fully remote, hybrid, and in-person PrEP care options. Consultations from the HIV prevention program are easily integrated into a patient's comprehensive care at Mount Sinai, ensuring a seamless and holistic approach to preventive and primary care management. "PrEP works best when it fits your life; and now you can start it online, on your own time, at your convenience," said Antonio E. Urbina, MD, Medical Director of the Institute for Advanced Medicine at the Icahn School of Medicine at Mount Sinai. The collaboration reflects Wisp's expansion beyond direct-to-consumer telehealth to working alongside health systems. By embedding its PrEP program within Mount Sinai's Institute for Advanced Medicine, which provides compassionate care to underserved groups regardless of background, ethnicity, or sexual orientation, Wisp is building a scalable hybrid care model that combines digital access with clinical depth. Launching during Pride Month, the partnership underscores a shared commitment to expanding HIV prevention at a time when public health progress is under pressure. ABOUT MOUNT SINAI: Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 47,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and leading schools of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time - discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care from conception through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients' medical and emotional needs at the center of all treatment. The Health System includes more than 6,400 primary and specialty care physicians and 10 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek's(R)"The World's Best Smart Hospitals," "Best in State Hospitals," "World's Best Hospitals," and "Best Specialty Hospitals" and by U.S. News & World Report's(R)"Best Hospitals" and "Best Children's Hospitals." The Mount Sinai Hospital is on the U.S. News & World Report(R)"Best Hospitals" Honor Roll for 2025-2026. ABOUT WISP: Wisp is the complete health platform built for women and their partners - delivering care on your terms, across every life stage. Trusted by over 1.8 million people nationwide, their licensed providers offer expert treatment for everything from urgent needs like UTIs and birth control to ongoing conditions like PCOS and perimenopause. Their asynchronous care model means no appointments and no waiting rooms. Whether you need same-day relief or long-term support, Wisp evolves with you, offering clinical expertise, zero judgment, and the continuity you deserve. Recognized by Inc. as Best in Business 2025, TIME as Best Inventions of 2025, and Clio as Best Campaign in Health Equity of 2025. Wisp is majority-owned by WELL Health Technologies Corp. Visit hellowisp.com or follow @hellowisp on social media. More News From Wisp NEW YORK-( BUSINESS WIRE )-Wisp, the largest pure play women's telehealth company in the U.S., today announced a partnership with Visby Medical, a leader in rapid at-home PCR diagnostics, in recognition of STI Awareness Week. Through the partnership, the two companies will expand access to Visby's FDA-authorized at-home PCR STI test, with Wisp providing follow-up telehealth care for patients who test positive for chlamydia, gonorrhea, or trichomoniasis. According to the World Health Organizatio... NEW YORK-( BUSINESS WIRE )-Wisp, the largest women's telehealth company in the U.S., today announced its expansion into clinician-guided longevity care with the launch of its new Longevity and Healthy Aging category. The initial offering features five science-backed treatments - glutathione (nasal spray and injection), NAD+ (nasal spray and injection), and low-dose naltrexone (LDN) - which work to optimize your biology by fueling cellular energy and repair and recalibrate the immune system. The... NEW YORK-( BUSINESS WIRE )-Wisp, the largest women's telehealth company in the U.S., today announced the acquisition of TBD Health, a national sexual health platform and one of the nation's most scaled TelePrEP infrastructures with deep partnerships with hospital systems, enterprises, and public health organizations. This marks Wisp's first acquisition and milestone expansion beyond direct-to-consumer care, into enterprise and hybrid care models. Care is delivered outside of traditional clinica... Wisp. Release Versions

ADDING MULTIMEDIA: Wisp and Visby Medical partner to provide care with the first fda-authorized at-home PCR STI test. The Largest Women's Telehealth Provider Expands Access to Rapid, High-Quality Sexual Health Solutions NEW YORK-(BUSINESS WIRE)-Wisp, the largest pure play women's telehealth company in the U.S., today announced a partnership with Visby Medical, a leader in rapid at-home PCR diagnostics, in recognition of STI Awareness Week. Through the partnership, the two companies will expand access to Visby's FDA-authorized at-home PCR STI test, with Wisp providing follow-up telehealth care for patients who test positive for chlamydia, gonorrhea, or trichomoniasis. According to the World Health Organization, more than one million curable STIs are acquired every day worldwide among people aged 15-49, most without symptoms, which can lead to lasting health effects if left untreated. Nearly 100,000 women in the U.S. lose their fertility each year due to complications from untreated STIs. Recognizing the overlap with their patient populations, Wisp and Visby aim to meet this critical need by making STI testing discreet, accessible, and significantly faster than conventional care pathways. The program will initially be offered through targeted patient outreach, with plans to expand access over time. The palm-sized Women's Sexual Health PCR test delivers lab-quality results in 30 minutes via Visby's mobile app. Patients who test positive are referred to Wisp and receive a complimentary virtual consultation with a licensed Wisp provider, and when clinically appropriate, antibiotics are prescribed immediately - all from the privacy of home. "This partnership came directly from listening to our patients," said Monica Cepak, CEO of Wisp. "Women are asking for faster answers and more seamless next steps. By pairing Visby's FDA-authorized at-home PCR test with Wisp's care model, we're delivering on our mission to support women across every life stage with fast, private, and stigma-free care." Chlamydia, gonorrhea, and trichomoniasis are the most common curable STIs and can be treated effectively with antibiotics. Wisp's platform removes barriers to care through secure online consultations with a licensed medical provider, personalized care plans, and confidential treatment pathways. The test is an eligible expense for both FSA and HSA accounts. "By providing timely medical advice through telehealth, the value of the Visby at-home sexual health test significantly increases," said Dr. Gary Schoolnik, Chief Medical Officer at Visby Medical and Professor of Medicine at Stanford Medical School. "This ensures that women who use the Visby test will receive prompt and effective advice and a path to treatment, if indicated." Looking ahead, Wisp and Visby plan to expand access to this integrated testing and care model, reaching more patients nationwide and continuing to reduce the time between diagnosis and treatment. As demand for discreet, at-home healthcare solutions grows, the partnership reflects a shared commitment to reimagining sexual health care with speed, accessibility, and patient-centered design at the core. About Visby Medical(TM) Founded in 2012, Visby Medical is revolutionizing infectious disease diagnosis by empowering both physicians and patients to accurately test for infections anywhere, anytime, with laboratory accuracy. The company's proprietary technology platform delivers true PCR results in under 30 minutes through the world's first instrument-free, single-use PCR tests that fit in the palm of your hand. Visby is actively working to expand its platform by developing a broader menu of tests for the at-home setting. For more information, visit visby.com. Follow Visby Medical on LinkedIn. ABOUT WISP: Wisp is the largest pure play women's telehealth provider in the U.S., serving 1.8+ million patients nationwide. Offering discreet, online care and a comprehensive range of first-to-market products, Wisp addresses women's health needs across every stage of life - from birth control to fertility, menopause, STI testing, and at-home diagnostics. Recognized by Inc. as Best in Business 2025, TIME as Best Inventions of 2025, and Clio as Best Campaign in Health Equity of 2025. Wisp is majority-owned by WELL Health Technologies Corp. Visit hellowisp.com or follow @hellowisp on social media. More News From Wisp NEW YORK-( BUSINESS WIRE )-Wisp, the largest women's telehealth company in the U.S., today announced its expansion into clinician-guided longevity care with the launch of its new Longevity and Healthy Aging category. The initial offering features five science-backed treatments - glutathione (nasal spray and injection), NAD+ (nasal spray and injection), and low-dose naltrexone (LDN) - which work to optimize your biology by fueling cellular energy and repair and recalibrate the immune system. The... NEW YORK-( BUSINESS WIRE )-Wisp, the largest women's telehealth company in the U.S., today announced the acquisition of TBD Health, a national sexual health platform and one of the nation's most scaled TelePrEP infrastructures with deep partnerships with hospital systems, enterprises, and public health organizations. This marks Wisp's first acquisition and milestone expansion beyond direct-to-consumer care, into enterprise and hybrid care models. Care is delivered outside of traditional clinica... NEW YORK-( BUSINESS WIRE )-Wisp, the largest pure play women's telehealth company in the U.S., today announced the launch of a dedicated migraine care vertical, consisting of online consults, prescription medications, and ongoing follow-up to help patients manage and prevent migraines. Wisp's migraine specialists, certified by the National Headache Foundation, create customized treatment plans, expanding access to affordable, convenient care for patients wherever they are. Migraines affect one... Wisp. Release Versions